Taewon Building
91 Ogeum-ro Songpa-gu
Seoul 05548
South Korea
82 2 2240 4000
https://www.seegene.com
Sector(s):
Industry:
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Jong-Yoon Chun | Founder, CEO, CTO & Director | N/A | N/A | 1957 |
Jong-Gi Cheon | Vice President and Chairman of Seegene Medical Foundation | N/A | N/A | 1962 |
Mr. Jin-Soo Choi | Executive VP & Director | N/A | N/A | 1952 |
Dr. Richard S. Creager Ph.D. | CEO of Seegene Technologies | N/A | N/A | 1953 |
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Seegene, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 7; Compensation: 9.